161 related articles for article (PubMed ID: 10495436)
1. Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells.
Berger W; Setinek U; Mohr T; Kindas-Mügge I; Vetterlein M; Dekan G; Eckersberger F; Caldas C; Micksche M
Int J Cancer; 1999 Oct; 83(3):415-23. PubMed ID: 10495436
[TBL] [Abstract][Full Text] [Related]
2. Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines.
Chandler LA; Sosnowski BA; Greenlees L; Aukerman SL; Baird A; Pierce GF
Int J Cancer; 1999 May; 81(3):451-8. PubMed ID: 10209961
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
[TBL] [Abstract][Full Text] [Related]
4. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
5. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
[TBL] [Abstract][Full Text] [Related]
7. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands.
McLeskey SW; Ding IY; Lippman ME; Kern FG
Cancer Res; 1994 Jan; 54(2):523-30. PubMed ID: 7506125
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.
Strutz F; Zeisberg M; Hemmerlein B; Sattler B; Hummel K; Becker V; Müller GA
Kidney Int; 2000 Apr; 57(4):1521-38. PubMed ID: 10760088
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
Fischer H; Taylor N; Allerstorfer S; Grusch M; Sonvilla G; Holzmann K; Setinek U; Elbling L; Cantonati H; Grasl-Kraupp B; Gauglhofer C; Marian B; Micksche M; Berger W
Mol Cancer Ther; 2008 Oct; 7(10):3408-19. PubMed ID: 18852144
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer.
Leung HY; Gullick WJ; Lemoine NR
Int J Cancer; 1994 Dec; 59(5):667-75. PubMed ID: 7960240
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines.
Kleeff J; Kothari NH; Friess H; Fan H; Korc M
Pancreas; 2004 Jan; 28(1):25-30. PubMed ID: 14707726
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro.
Volm M; Koomägi R; Mattern J; Stammler G
Anticancer Res; 1997; 17(1A):99-103. PubMed ID: 9066636
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
14. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Olson DC; Hanahan D
Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas.
Volm M; Koomägi R; Mattern J; Stammler G
Eur J Cancer; 1997 Apr; 33(4):691-3. PubMed ID: 9274456
[TBL] [Abstract][Full Text] [Related]
17. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.
Kuhn H; Köpff C; Konrad J; Riedel A; Gessner C; Wirtz H
Lung Cancer; 2004 May; 44(2):167-74. PubMed ID: 15084381
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
19. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor.
Gonzalez AM; Logan A; Ying W; Lappi DA; Berry M; Baird A
Endocrinology; 1994 May; 134(5):2289-97. PubMed ID: 8156932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
